Entity Common Stock, Shares Outstanding of Sage Therapeutics, Inc. from 01 Aug 2014 to 23 Jul 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Sage Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 01 Aug 2014 to 23 Jul 2025.
  • Sage Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 23 Jul 2025 was 62,784,397, a 2.8% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Sage Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 62,784,397 +1,733,979 +2.8% 23 Jul 2025 10-Q 30 Jul 2025 2025 Q2
Q1 2025 62,620,694 +2,438,663 +4.1% 22 Apr 2025 10-Q 29 Apr 2025 2025 Q1
Q4 2024 61,480,947 +1,374,260 +2.3% 04 Feb 2025 10-K 11 Feb 2025 2024 FY
Q3 2024 61,173,263 +1,205,747 +2% 22 Oct 2024 10-Q 29 Oct 2024 2024 Q3
Q2 2024 61,050,418 +1,166,475 +1.9% 24 Jul 2024 10-Q 31 Jul 2024 2024 Q2
Q1 2024 60,182,031 +419,925 +0.7% 18 Apr 2024 10-Q 25 Apr 2024 2024 Q1
Q4 2023 60,106,687 +389,079 +0.65% 07 Feb 2024 10-K 14 Feb 2024 2023 FY
Q3 2023 59,967,516 +473,812 +0.8% 31 Oct 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 59,883,943 +461,600 +0.78% 01 Aug 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 59,762,106 +695,957 +1.2% 25 Apr 2023 10-Q 02 May 2023 2023 Q1
Q4 2022 59,717,608 08 Feb 2023 10-K 16 Feb 2023 2022 FY
Q3 2022 59,493,704 +585,219 +0.99% 01 Nov 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 59,422,343 +611,192 +1% 27 Jul 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 59,066,149 +586,131 +1% 26 Apr 2022 10-Q 03 May 2022 2022 Q1
Q3 2021 58,908,485 +6,863,822 +13% 26 Oct 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 58,811,151 +6,836,882 +13% 27 Jul 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 58,480,018 +6,562,199 +13% 27 Apr 2021 10-Q 04 May 2021 2021 Q1
Q3 2020 52,044,663 +227,134 +0.44% 29 Oct 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 51,974,269 +317,276 +0.61% 04 Aug 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 51,917,819 +770,121 +1.5% 30 Apr 2020 10-Q 07 May 2020 2020 Q1
Q3 2019 51,817,529 +4,930,355 +11% 06 Nov 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 51,656,993 +4,992,697 +11% 31 Jul 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 51,147,698 +4,631,840 +10% 25 Apr 2019 10-Q 02 May 2019 2019 Q1
Q4 2018 47,092,657 12 Feb 2019 10-K 19 Feb 2019 2018 FY
Q3 2018 46,887,174 +9,349,519 +25% 31 Oct 2018 10-Q 06 Nov 2018 2018 Q3
Q2 2018 46,664,296 +9,223,212 +25% 01 Aug 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 46,515,858 +9,169,569 +25% 26 Apr 2018 10-Q 03 May 2018 2018 Q1
Q3 2017 37,537,655 +370,481 +1% 30 Oct 2017 10-Q 02 Nov 2017 2017 Q3
Q2 2017 37,441,084 +5,347,064 +17% 31 Jul 2017 10-Q 03 Aug 2017 2017 Q2
Q1 2017 37,346,289 +5,282,742 +16% 03 May 2017 10-Q 10 May 2017 2017 Q1
Q3 2016 37,167,174 +8,304,703 +29% 01 Nov 2016 10-Q 03 Nov 2016 2016 Q3
Q2 2016 32,094,020 +3,272,768 +11% 01 Aug 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 32,063,547 +6,254,859 +24% 29 Apr 2016 10-Q 06 May 2016 2016 Q1
Q3 2015 28,862,471 +3,069,848 +12% 01 Nov 2015 10-Q 06 Nov 2015 2015 Q3
Q2 2015 28,821,252 +3,109,326 +12% 01 Aug 2015 10-Q 12 Aug 2015 2015 Q2
Q1 2015 25,808,688 01 Mar 2015 10-K 06 Mar 2015 2014 FY
Q3 2014 25,792,623 01 Nov 2014 10-Q 13 Nov 2014 2014 Q3
Q2 2014 25,711,926 01 Aug 2014 10-Q 14 Aug 2014 2014 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.